A Catalan public tender for outpatient haemodialysis has reached its proposed award stage after appeals and challenges delayed the process launched in January 2025. The contracting committee has referred its recommendation to the Servei Català de la Salut, or CatSalut, with Diaverum and Fresenius set to receive most of the work.
Two operators take most of the work
Diaverum, the Swedish renal-care group owned by G42 and Mubadala, has been proposed for seven of the tender’s 18 lots, with a combined budget of €184 million. Its areas include Terres de l’Ebre, L’Hospitalet de Llobregat, the zone covering Barcelonès Nord and Baix Maresme, and four of the five divisions covering Barcelona. The company also bid for eight further lots that have gone to other operators. Fresenius, the German healthcare multinational and owner of the Quirónsalud hospital group, has been proposed for six lots worth about €143 million.
The contract covers regional dialysis services
The winning proposals divide outpatient haemodialysis services for patients with chronic renal failure across defined territorial lots. Fresenius is set to operate in Baix Camp and Priorat, the coastal area of Baix Llobregat, central Maresme, western Vallès Occidental, central Vallès Oriental and the fifth Barcelona lot. Sistemas Renals, a Lleida-based company specialising in dialysis units, has been proposed for Lleida and Alt Pirineu and for Baix Penedès, with a budget of €37 million. B. Braun is initially assigned two lots, including Alt Maresme and Selva Marítima and Baix Llobregat Nord.
A multi-lot tender spreads the award
Dividing a procurement into lots allows a contracting authority to specify separate geographical or service packages and to appoint different suppliers rather than awarding the entire requirement as one contract. In this case, the remaining participation includes local specialist Sistemas Renals, B. Braun and Avericum, as well as Gesat, a public company owned by Tortosa council that was the only other bidder for the Terres de l’Ebre lot. The arrangement gives several operators a route into the contract while allocating each service area through the same tender.
One proposal still requires more evidence
The proposed award is not entirely settled. Lot number three, assigned to Avericum for €19 million, remains dependent on the company submitting additional documents to substantiate its proposal. The committee’s recommendation must also be considered by CatSalut, the contracting body. The process has already been delayed by several challenges and appeals since its launch in January 2025. The contract has a budget of €415 million and runs for five years, while the wider tender value reaches €498 million when extensions are included. The previous contract expired in 2024.
| Fact | Value |
|---|---|
| Total tender value including extensions | €498 million |
| Number of lots | 18 |
| Diaverum lots | 7 |
| Diaverum budget | €184 million |
| Fresenius lots | 6 |
| Fresenius amount | About €143 million |
| Contract term | Five years |
| Contract budget | €415 million |
Diaverum has become the Generalitat’s largest contract awardee, with seven of the 18 lots.
WHY IT MATTERS
The case shows how a large healthcare procurement can use geographical lots to divide delivery among several providers. It also illustrates the distinction between a tender committee’s proposed award and a completed contract: CatSalut must consider the recommendation, and Avericum must provide additional documents for one lot.
Reported from expansion.com, 2026-11-17. The Tender Wire is published by Otnox.